Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions

Click Here To Save Now

Resources

Aug 11, 2025

EyePoint completes enrollment in second phase 3 trial of sustained-release AMD therapy

ByJay S. Duker, MD ByAlex Young ByAnthony DeFino Fact checked by Christine Klimanskis, ELS Key takeaways: More than 400 patients

EyePoint completes enrollment in second phase 3 trial of sustained-release AMD therapy

Aug 11, 2025

This common fruit has over 1,600 compounds that boost brain, heart, and gut health

Published August 6, 2025 | Originally published on ScienceDaily Top Health A new article appearing in the current issue of the peer-reviewed Journal of

This common fruit has over 1,600 compounds that boost brain, heart, and gut health

Aug 6, 2025

Study supports Iluvien as ‘long-acting option’ in diabetic macular edema

Key takeaways: The NEW DAY study did not meet its primary endpoint but showed good outcomes in secondary endpoints. A

Study supports Iluvien as ‘long-acting option’ in diabetic macular edema

Aug 5, 2025

Geographic Atrophy Patient Experience Research

A new study is being conducted on geographic atrophy. They would like to hear about your experience with the drug

Geographic Atrophy Patient Experience Research

Jul 31, 2025

Phase 3 study of LUMIFY Preservative Free and LUMIFY eye drops meets primary end point

Author(s): Jordana Joy Key Takeaways LUMIFY Preservative Free eye drops are statistically non-inferior to LUMIFY in reducing ocular redness, with

Phase 3 study of LUMIFY Preservative Free and LUMIFY eye drops meets primary end point

Jul 28, 2025

VA-developed RainDrop Dispenser Aid aims to simplify use of single-use eye drops for patients with arthritis, tremors July 24, 2025

July 24, 2025 by Lynda Charters, Jordana Joy, Associate Editor Rain Eye Drops LLC announced the launch of a newly

VA-developed RainDrop Dispenser Aid aims to simplify use of single-use eye drops for patients with arthritis, tremors July 24, 2025

Jul 24, 2025

Novel AI-powered retina tracker detects eye disease in under one second

By: The Endocrine Society A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according

Novel AI-powered retina tracker detects eye disease in under one second

Jul 24, 2025

Oral danegaptide for diabetic retinopathy successfully completes phase 1b trial

By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: Danegaptide could be an oral therapy for patients with

Oral danegaptide for diabetic retinopathy successfully completes phase 1b trial

Jul 24, 2025

Survey finds majority of US patients delaying eye care despite experiencing poor eyesight, eye health

By: Jordana Joy, Associate Editor Survey participants cited cost concerns, perceived inevitability, and deprioritization as obstacles to receiving eye care.

Survey finds majority of US patients delaying eye care despite experiencing poor eyesight, eye health

Jul 24, 2025

FDA fast tracks one-time intravitreal gene therapy for geographic atrophy

By: Anthony DeFino Fact checked by: Christine Klimanskis, ELS Key takeaways: SAR446597 is designed to inhibit C1s and factor Bb

FDA fast tracks one-time intravitreal gene therapy for geographic atrophy

Jul 8, 2025

Alcon to acquire LumiThera and its photobiomodulation device for the treatment of dry AMD

Author(s): Martin David Harp Key Takeaways Alcon’s acquisition of LumiThera includes a PBM device for early and intermediate dry AMD,

Alcon to acquire LumiThera and its photobiomodulation device for the treatment of dry AMD

Jul 8, 2025

Can you eye doctor predict an impending stroke?

A university study shows certain types of retina problems are early signs of stroke. Research scientists from the University of

Can you eye doctor predict an impending stroke?

Jul 3, 2025

Happy Independence Day

    The Macular Degeneration Association would like to wish everyone a safe and excellent 4th of July. The offices

Happy Independence Day

Jun 30, 2025

36-month results from phase 1/2a clinical study of RG6501 released

Author(s): Kassi Filkins Key Takeaways RG6501 (OpRegen) cell therapy shows sustained visual acuity and retinal structure improvements in GA patients

36-month results from phase 1/2a clinical study of RG6501 released

Jun 30, 2025

Redefining retinal care: Ixo-vec gene therapy for nAMD enters phase 3

Author(s): Glenn Yiu, MD, PhD Fact checked by: Sheryl Stevenson Frequent intravitreal injections for neovascular age-related macular degeneration present a

Redefining retinal care: Ixo-vec gene therapy for nAMD enters phase 3

Jun 23, 2025

Instant coffee can cause blindness, says report

Published in Food Science & Nutrition, the study examined a large genetic dataset of more than 5,00,000 people and used

Instant coffee can cause blindness, says report

Jun 19, 2025

ILYX-002 rapidly improves immune-mediated dry eye disease in phase 2 trial

By Justin Cooper Fact checked by Christine Klimanskis, ELS Key takeaways: Dry eye disease associated with systemic autoimmune or inflammatory

ILYX-002 rapidly improves immune-mediated dry eye disease in phase 2 trial

Jun 16, 2025

Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT

Author(s): Christine Curcio, PhD, Sheryl Stevenson Conferences|International SPECTRALIS Symposium – and Beyond From basal laminar deposits to foveal centering, a

Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT

Jun 16, 2025

Cataract surgery may curb dementia, Alzheimer’s risk in those without anxiety, depression

By Justin Cooper Fact checked by Christine Klimanskis, ELS Key takeaways: Cataract surgery had a protective effect against overall dementia

Cataract surgery may curb dementia, Alzheimer’s risk in those without anxiety, depression

Jun 16, 2025

Undiagnosed AMD prevalence in urban setting higher than national average

By Alex Young Fact checked by Eamon N. Dreisbach Key takeaways: A hospital in New York had a higher percentage

Undiagnosed AMD prevalence in urban setting higher than national average

Jun 12, 2025

FDA nod for acoltremon: What its approval means for clinicians and patients

Author(s): Sheryl Stevenson Alcon’s announcement of the FDA approval for its acoltremon ophthalmic solution 0.003% (Tryptyr; formerly AR-15512) for the

FDA nod for acoltremon: What its approval means for clinicians and patients

Jun 10, 2025

Press Release PAO Action Week

Press Release   Hello, The Macular Degeneration Association is one of the 1,200+ patient advocacy organizations (PAOs) in the United

Press Release PAO Action Week

Jun 10, 2025

Home OCT a ‘safety net’ for reducing treatment burden in wet AMD

ByAnthony DeFino Fact checked byChristine Klimanskis, ELS Key takeaways: Home OCT may help patients achieve extended dosing intervals through consistent

Home OCT a ‘safety net’ for reducing treatment burden in wet AMD

Jun 2, 2025

Stop Smoking Now to Protect Your Vision, Experts Warn

Edited by Shrabasti Bhattacharya TOPLINE: Current smokers faced up to 12-fold higher risk for age-related macular degeneration, a threefold higher

Stop Smoking Now to Protect Your Vision, Experts Warn

May 27, 2025

Aldeyra Therapeutics hits primary end point in 1 of 2 phase 3 trials for reproxalap

Author(s): Emily Kaiser Maharjan Key Takeaways Aldeyra’s phase 3 trial of reproxalap showed statistical superiority in reducing ocular discomfort compared

Aldeyra Therapeutics hits primary end point in 1 of 2 phase 3 trials for reproxalap

May 26, 2025

Remember and Honor Our Fallen Heroes

“Their sacrifice was the ultimate act of love for their country. May we always remember them.” — Unknown

Remember and Honor Our Fallen Heroes

May 16, 2025

PARTICIPATE IN A MARKET RESEARCH STUDY ON VISUAL IMPAIRMENTS

Exafield US, a healthcare market research company based in the USA, is conducting a study on visual impairments and would

PARTICIPATE IN A MARKET RESEARCH STUDY ON VISUAL IMPAIRMENTS

May 15, 2025

Living with GA: How patients in the US and Western Europe cope

Living with GA: How patients in the US and Western Europe cope Author(s): Lynda Charters Key Takeaways Geographic atrophy significantly

Living with GA: How patients in the US and Western Europe cope

May 15, 2025

The eSight GO

By: Jeffry Gerson, OD, FAAO- Medical Director for the Macular Degeneration Association When we were at our recent in-person seminar

The eSight GO

May 15, 2025

Valeda® Light Delivery System: The First FDA-Approved Treatment for Dry AMD

By: Jeffry Gerson, OD, FAAO- Medical Director for the Macular Degeneration Association Photobiomodulation (PBM) is a new treatment that was

Valeda® Light Delivery System: The First FDA-Approved Treatment for Dry AMD

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.